Mirae Asset Global Investments Co. Ltd. Acquires 2,863 Shares of Agilent Technologies, Inc. $A

Key Points

• Mirae Asset Global Investments Co. Ltd. increased its stake in Agilent Technologies by 7.8% during the second quarter, acquiring an additional 2,863 shares to hold a total of 39,537 shares valued at $4.67 million.
• Agilent Technologies announced a quarterly dividend of $0.248 per share, translating to an annualized dividend yield of 0.7%, with an ex-dividend date of September 30th.
• Different analysts have varied ratings for Agilent, with six giving a "Buy" rating and seven a "Hold" rating, reflecting a consensus price target of $142.17 for the stock.

Mirae Asset Global Investments Co. Ltd. grew its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 7.8% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,537 shares of the medical research company's stock after buying an additional 2,863 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in Agilent Technologies were worth $4,666,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Stone House Investment Management LLC purchased a new position in Agilent Technologies in the first quarter worth about $30,000. Opal Wealth Advisors LLC purchased a new position in shares of Agilent Technologies in the 1st quarter worth approximately $31,000. Ransom Advisory Ltd bought a new position in shares of Agilent Technologies during the 1st quarter valued at approximately $32,000. Central Pacific Bank Trust Division bought a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $33,000. Finally, Zions Bancorporation National Association UT purchased a new stake in Agilent Technologies during the 1st quarter valued at $38,000.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Agilent Technologies in a research note on Saturday, September 27th. Robert W. Baird lifted their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research note on Thursday, August 28th. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Friday. Evercore ISI decreased their price objective on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a research note on Thursday, August 28th. Finally, Barclays upped their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an "equal weight" rating in a research note on Thursday, October 2nd. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $142.17.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $141.64 on Tuesday. The business's 50 day moving average is $123.24 and its 200 day moving average is $116.49. The stock has a market cap of $40.15 billion, a P/E ratio of 33.25, a price-to-earnings-growth ratio of 4.62 and a beta of 1.26. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the firm earned $1.32 earnings per share. The firm's revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 30th. Agilent Technologies's dividend payout ratio is currently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.